Authors
Latest:
How Pharmacists Can Help Patients Save MoneyMedication is not cheap, but we can help ensure that cost is not a barrier to adherence. Here are some tips.
Latest:
McCurdy Advances the Profession of Pharmacy Through Strong Community SpiritThis month's RESPy winner, UCSF School of Pharmacy's Megan McCurdy, is a true champion of community volunteerism and advancing the pharmacy profession.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
Latest:
Bispecific Antibodies: The Next Generation of ImmunotherapyAdvances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Latest:
Rare Pharmacy Emerges From Specialty, Part 2Challenges and impact of rare diseases are faced by pharmacy stakeholders.
Latest:
Initiating an Antimicrobial Stewardship Program: The Costs and the BenefitsFor decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
The Impending Patent Cliff: Implications for PharmacistsAs blockbuster drugs begin losing patent protection, pharmaceutical companies and pharmacists will address key marketplace changes.
Latest:
Specialty Pharmacy: Making a DifferenceWe welcome our new editorial advisory board member, a leader and innovator in the industry.
Latest:
Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionPharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Latest:
Pharmacist In Action: Pandemic Delivers Student a Unique RotationBen Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.
Latest:
Hypertension: Revealing the Silent KillerHypertension is a leading modifiable risk factor for heart disease and stroke.
Latest:
Generic Drug Trends-What's Next?Big changes are coming in the generic marketplace worldwide in the coming decade.
Latest:
Case Studies (January 2020)What could be causing this patient's involuntary, repetitive movements in her arms and legs?
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE ProphylaxisThis analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.
Latest:
Trends That Will Affect Specialty Health Care Into the FutureÂCurrent developments and innovations that will shape the future of specialty pharmacy.
Latest:
The Benefits of the Hub for Specialty PatientsPharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
The Road to WellnessA chain pharmacy implements an integrated care program featuring pharmacists and health care coaches who provide in-store counseling.
Latest:
Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's ContractureA retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
Safe Handling of Oral Chemo Agents in Community SettingsDr. Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey and associate professor of medicine, division of medical oncology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick.
Latest:
Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and DiacereinEmpirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.
